November 18, 2013
Stories this photo appears in:
The Food and Drug Administration has warned CareFusion 2200 Inc., a subsidiary of San Diego-based CareFusion Corp., that it failed to satisfactorily investigate and respond to 32 complaints of particulate matter and debris found in certain medical devices
CareFusion announced the commercial launch of its new micro-laparoscopic line of surgical instruments.
San Diego medical device maker CareFusion Corp. has priced three series of senior unsecured notes for an aggregate principal amount of $1 billion.
Third-quarter revenue for CareFusion Corp. rose a little more than 7 percent to $968 million compared with the prior year’s third quarter.
Second-quarter profit for San Diego medical device maker CareFusion Corp. dropped 10 percent despite higher-than-expected revenue growth, due in part to the company’s heavy expenses in the quarter.
CareFusion Corp. has agreed to pay the government $40.1 million to settle allegations from a whistleblower that it paid kickbacks to increase product sales, as well as marketed the product for uses that aren’t approved by the Food and Drug Administration.
San Diego-based CareFusion Corp. said it will acquire Vital Signs, a division of GE Healthcare, for $500 million as CareFusion moves to increase its respiratory care and anesthesiology businesses.